

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neuronal action potential propagation (GO:0019227) | 3.86599432 |
| 2 | central nervous system myelination (GO:0022010) | 3.82278750 |
| 3 | axon ensheathment in central nervous system (GO:0032291) | 3.82278750 |
| 4 | locomotory exploration behavior (GO:0035641) | 3.62351566 |
| 5 | vocalization behavior (GO:0071625) | 3.55158159 |
| 6 | L-amino acid import (GO:0043092) | 3.50030695 |
| 7 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.48585871 |
| 8 | neuron cell-cell adhesion (GO:0007158) | 3.39140220 |
| 9 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.35231251 |
| 10 | synaptic vesicle exocytosis (GO:0016079) | 3.26295499 |
| 11 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.26195926 |
| 12 | glutamate receptor signaling pathway (GO:0007215) | 3.25646845 |
| 13 | C4-dicarboxylate transport (GO:0015740) | 3.24693356 |
| 14 | glutamate secretion (GO:0014047) | 3.23159828 |
| 15 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.22561108 |
| 16 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.19970018 |
| 17 | gamma-aminobutyric acid transport (GO:0015812) | 3.16032120 |
| 18 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.11753968 |
| 19 | presynaptic membrane assembly (GO:0097105) | 3.11143718 |
| 20 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.10590603 |
| 21 | presynaptic membrane organization (GO:0097090) | 3.06435168 |
| 22 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.03214502 |
| 23 | transmission of nerve impulse (GO:0019226) | 3.02405823 |
| 24 | actin-myosin filament sliding (GO:0033275) | 3.01297384 |
| 25 | muscle filament sliding (GO:0030049) | 3.01297384 |
| 26 | regulation of p38MAPK cascade (GO:1900744) | 2.98911986 |
| 27 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.95692635 |
| 28 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.94809410 |
| 29 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.93984874 |
| 30 | neuron-neuron synaptic transmission (GO:0007270) | 2.93633596 |
| 31 | protein localization to synapse (GO:0035418) | 2.88456270 |
| 32 | neuron remodeling (GO:0016322) | 2.85470102 |
| 33 | amino acid import (GO:0043090) | 2.84570938 |
| 34 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.84143526 |
| 35 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.83259594 |
| 36 | synaptic vesicle maturation (GO:0016188) | 2.82911210 |
| 37 | behavioral response to cocaine (GO:0048148) | 2.82080267 |
| 38 | synaptic transmission, glutamatergic (GO:0035249) | 2.80885157 |
| 39 | long term synaptic depression (GO:0060292) | 2.78631896 |
| 40 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.78152949 |
| 41 | exploration behavior (GO:0035640) | 2.76893381 |
| 42 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.75989663 |
| 43 | cerebellar granule cell differentiation (GO:0021707) | 2.74841413 |
| 44 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.74814321 |
| 45 | neuron recognition (GO:0008038) | 2.74603798 |
| 46 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.73838060 |
| 47 | long-term synaptic potentiation (GO:0060291) | 2.73677204 |
| 48 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.73393351 |
| 49 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.73248678 |
| 50 | regulation of relaxation of muscle (GO:1901077) | 2.71832572 |
| 51 | creatine metabolic process (GO:0006600) | 2.71080203 |
| 52 | cellular potassium ion homeostasis (GO:0030007) | 2.69803445 |
| 53 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.69109145 |
| 54 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.67912973 |
| 55 | positive regulation of p38MAPK cascade (GO:1900745) | 2.67907390 |
| 56 | detection of calcium ion (GO:0005513) | 2.67405621 |
| 57 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.67194948 |
| 58 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.67036322 |
| 59 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.66678868 |
| 60 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.66321059 |
| 61 | negative regulation of neurotransmitter transport (GO:0051589) | 2.65478299 |
| 62 | long-term memory (GO:0007616) | 2.64042708 |
| 63 | myofibril assembly (GO:0030239) | 2.63752981 |
| 64 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.62769064 |
| 65 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.61002436 |
| 66 | sodium ion export (GO:0071436) | 2.60916331 |
| 67 | regulation of postsynaptic membrane potential (GO:0060078) | 2.56435299 |
| 68 | cardiac muscle contraction (GO:0060048) | 2.55603186 |
| 69 | neurotransmitter secretion (GO:0007269) | 2.55590768 |
| 70 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.55328525 |
| 71 | actin-mediated cell contraction (GO:0070252) | 2.54212832 |
| 72 | striated muscle hypertrophy (GO:0014897) | 2.53560270 |
| 73 | regulation of synaptic plasticity (GO:0048167) | 2.53335821 |
| 74 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.53098186 |
| 75 | regulation of synaptic vesicle transport (GO:1902803) | 2.52655270 |
| 76 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.52312753 |
| 77 | cardiac muscle hypertrophy (GO:0003300) | 2.50547816 |
| 78 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.50341466 |
| 79 | regulation of dendritic spine development (GO:0060998) | 2.49844609 |
| 80 | complement activation, alternative pathway (GO:0006957) | 2.48674969 |
| 81 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.47673103 |
| 82 | myelination (GO:0042552) | 2.47586690 |
| 83 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.47348647 |
| 84 | regulation of skeletal muscle contraction (GO:0014819) | 2.46685389 |
| 85 | dendritic spine morphogenesis (GO:0060997) | 2.46547885 |
| 86 | response to inactivity (GO:0014854) | 2.45079915 |
| 87 | axon ensheathment (GO:0008366) | 2.44338695 |
| 88 | ensheathment of neurons (GO:0007272) | 2.44338695 |
| 89 | response to epinephrine (GO:0071871) | 2.43494467 |
| 90 | negative regulation of protein localization to cell surface (GO:2000009) | 2.43380916 |
| 91 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.42464973 |
| 92 | L-phenylalanine catabolic process (GO:0006559) | 2.42464973 |
| 93 | regulation of glutamate secretion (GO:0014048) | 2.41866841 |
| 94 | skeletal muscle adaptation (GO:0043501) | 2.41443394 |
| 95 | female mating behavior (GO:0060180) | 2.41374038 |
| 96 | neurotransmitter transport (GO:0006836) | 2.41320738 |
| 97 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.41282862 |
| 98 | axonal fasciculation (GO:0007413) | 2.41234822 |
| 99 | muscle hypertrophy (GO:0014896) | 2.40249274 |
| 100 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.39830448 |
| 101 | fatty acid elongation (GO:0030497) | 2.39644649 |
| 102 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.39523868 |
| 103 | regulation of actin filament-based movement (GO:1903115) | 2.38828756 |
| 104 | striated muscle contraction (GO:0006941) | 2.38269955 |
| 105 | protein targeting to Golgi (GO:0000042) | 2.37337498 |
| 106 | response to histamine (GO:0034776) | 2.36241029 |
| 107 | neuronal ion channel clustering (GO:0045161) | 2.36226554 |
| 108 | positive regulation of extracellular matrix organization (GO:1903055) | 2.35965644 |
| 109 | neuromuscular process controlling balance (GO:0050885) | 2.35921555 |
| 110 | cardiac myofibril assembly (GO:0055003) | 2.35634676 |
| 111 | regulation of vesicle fusion (GO:0031338) | 2.35239753 |
| 112 | neurotransmitter uptake (GO:0001504) | 2.34933046 |
| 113 | potassium ion import (GO:0010107) | 2.34820561 |
| 114 | mating behavior (GO:0007617) | 2.34707832 |
| 115 | negative regulation of synaptic transmission (GO:0050805) | 2.34396927 |
| 116 | regulation of cell communication by electrical coupling (GO:0010649) | 2.33897837 |
| 117 | cGMP-mediated signaling (GO:0019934) | 2.30977591 |
| 118 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.30839222 |
| 119 | response to methylmercury (GO:0051597) | 2.30287453 |
| 120 | regulation of female receptivity (GO:0045924) | 2.30088870 |
| 121 | postsynaptic membrane organization (GO:0001941) | 2.29998005 |
| 122 | skeletal muscle contraction (GO:0003009) | 2.29355470 |
| 123 | positive regulation of membrane potential (GO:0045838) | 2.28736333 |
| 124 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.28038458 |
| 125 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.27598846 |
| 126 | glutamate metabolic process (GO:0006536) | 2.26659481 |
| 127 | short-chain fatty acid metabolic process (GO:0046459) | 2.25892008 |
| 128 | relaxation of cardiac muscle (GO:0055119) | 2.25804566 |
| 129 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.24867526 |
| 130 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.24678205 |
| 131 | regulation of complement activation (GO:0030449) | 2.23611353 |
| 132 | regulation of neurotransmitter levels (GO:0001505) | 2.23569256 |
| 133 | positive regulation of dendritic spine development (GO:0060999) | 2.22653238 |
| 134 | cellular response to epinephrine stimulus (GO:0071872) | 2.22653001 |
| 135 | positive regulation of fibroblast migration (GO:0010763) | 2.22415964 |
| 136 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.21613742 |
| 137 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.21055132 |
| 138 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.20618936 |
| 139 | acidic amino acid transport (GO:0015800) | 2.20610635 |
| 140 | relaxation of muscle (GO:0090075) | 2.20062006 |
| 141 | neuromuscular process controlling posture (GO:0050884) | 2.19775068 |
| 142 | striated muscle adaptation (GO:0014888) | 2.19600643 |
| 143 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.19521414 |
| 144 | L-phenylalanine metabolic process (GO:0006558) | 2.19521414 |
| 145 | regulation of protein activation cascade (GO:2000257) | 2.18395512 |
| 146 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.17519637 |
| 147 | muscle hypertrophy in response to stress (GO:0003299) | 2.17519637 |
| 148 | cardiac muscle adaptation (GO:0014887) | 2.17519637 |
| 149 | cellular sodium ion homeostasis (GO:0006883) | 2.17518778 |
| 150 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.15790361 |
| 151 | actin filament-based movement (GO:0030048) | 2.15719326 |
| 152 | growth hormone receptor signaling pathway (GO:0060396) | 2.15530236 |
| 153 | negative regulation of complement activation (GO:0045916) | 2.15459936 |
| 154 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.13226118 |
| 155 | barbed-end actin filament capping (GO:0051016) | 2.11870326 |
| 156 | extracellular matrix assembly (GO:0085029) | 2.11204483 |
| 157 | response to mercury ion (GO:0046689) | 2.11091535 |
| 158 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.11000559 |
| 159 | regulation of ARF protein signal transduction (GO:0032012) | 2.10567427 |
| 160 | positive regulation of Rap GTPase activity (GO:0032854) | 2.08622039 |
| 161 | germinal center formation (GO:0002467) | 2.07302630 |
| 162 | muscle contraction (GO:0006936) | 2.06461954 |
| 163 | negative regulation of protein activation cascade (GO:2000258) | 2.05517396 |
| 164 | import into cell (GO:0098657) | 2.03023832 |
| 165 | regulation of macrophage cytokine production (GO:0010935) | 2.02908677 |
| 166 | response to laminar fluid shear stress (GO:0034616) | 2.01830289 |
| 167 | regulation of macrophage chemotaxis (GO:0010758) | 2.01582401 |
| 168 | negative regulation of fatty acid transport (GO:2000192) | 2.00825232 |
| 169 | response to muscle activity (GO:0014850) | 2.00385792 |
| 170 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 1.99490716 |
| 171 | cell volume homeostasis (GO:0006884) | 1.99081301 |
| 172 | cell communication by electrical coupling (GO:0010644) | 1.98449916 |
| 173 | regulation of calcium ion transmembrane transport (GO:1903169) | 1.97780432 |
| 174 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 1.97780432 |
| 175 | muscle system process (GO:0003012) | 1.97585529 |
| 176 | response to fluid shear stress (GO:0034405) | 1.97020131 |
| 177 | ovulation from ovarian follicle (GO:0001542) | 1.96945137 |
| 178 | sarcomere organization (GO:0045214) | 1.96276439 |
| 179 | regulation of energy homeostasis (GO:2000505) | 1.94004942 |
| 180 | regulation of striated muscle contraction (GO:0006942) | 1.92424266 |
| 181 | carnitine shuttle (GO:0006853) | 1.91608898 |
| 182 | regulation of the force of heart contraction (GO:0002026) | 1.91202478 |
| 183 | endocrine hormone secretion (GO:0060986) | 1.90968121 |
| 184 | activation of protein kinase A activity (GO:0034199) | 1.88839733 |
| 185 | regulation of muscle adaptation (GO:0043502) | 1.88501501 |
| 186 | cellular response to growth hormone stimulus (GO:0071378) | 1.88305305 |
| 187 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 1.87793008 |
| 188 | regulation of cardiac muscle hypertrophy (GO:0010611) | 1.87790215 |
| 189 | positive regulation of macrophage cytokine production (GO:0060907) | 1.87508834 |
| 190 | negative regulation of vascular permeability (GO:0043116) | 1.87080058 |
| 191 | regulation of muscle hypertrophy (GO:0014743) | 1.86967665 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.08628710 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.22929088 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.67788733 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.64841766 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.61711521 |
| 6 | * SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.40928922 |
| 7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.39687488 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.35193342 |
| 9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.26605006 |
| 10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.23266580 |
| 11 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.23266580 |
| 12 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.19959198 |
| 13 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.17112259 |
| 14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.11668468 |
| 15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.06086650 |
| 16 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.02286412 |
| 17 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.00393172 |
| 18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.98527555 |
| 19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.96094994 |
| 20 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.95990843 |
| 21 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.94653480 |
| 22 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.87468475 |
| 23 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.87042689 |
| 24 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.86386471 |
| 25 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.80825637 |
| 26 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.78946647 |
| 27 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.74321015 |
| 28 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.73837615 |
| 29 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.73543238 |
| 30 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.69371773 |
| 31 | GATA1_22025678_ChIP-Seq_K562_Human | 1.67863561 |
| 32 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.67854631 |
| 33 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.66061763 |
| 34 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.64537237 |
| 35 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.64236330 |
| 36 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.63105126 |
| 37 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.61513567 |
| 38 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.61513567 |
| 39 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.60771323 |
| 40 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.58557057 |
| 41 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.55258456 |
| 42 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.53853689 |
| 43 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.52847416 |
| 44 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.51400618 |
| 45 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.47439863 |
| 46 | VDR_22108803_ChIP-Seq_LS180_Human | 1.43575544 |
| 47 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.43088339 |
| 48 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.42867646 |
| 49 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.42490174 |
| 50 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.40712095 |
| 51 | P300_19829295_ChIP-Seq_ESCs_Human | 1.40392287 |
| 52 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.38778650 |
| 53 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.38197628 |
| 54 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.37402135 |
| 55 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.37313282 |
| 56 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.34934232 |
| 57 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.34084174 |
| 58 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.33794961 |
| 59 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.32953702 |
| 60 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.32795335 |
| 61 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.32603622 |
| 62 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.31968930 |
| 63 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.29935269 |
| 64 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.29924486 |
| 65 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.29656778 |
| 66 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.28777018 |
| 67 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.27835451 |
| 68 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.27334414 |
| 69 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.26628952 |
| 70 | TP53_16413492_ChIP-PET_HCT116_Human | 1.26445319 |
| 71 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.25771829 |
| 72 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.25651026 |
| 73 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.25651026 |
| 74 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.24876340 |
| 75 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.24645618 |
| 76 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.21298396 |
| 77 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.21080611 |
| 78 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.20655389 |
| 79 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.20632402 |
| 80 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.20523597 |
| 81 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.20392097 |
| 82 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.19914217 |
| 83 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.19195160 |
| 84 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.18670988 |
| 85 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.18536217 |
| 86 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.17788450 |
| 87 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.16774935 |
| 88 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.16560866 |
| 89 | KDM2B_26808549_Chip-Seq_K562_Human | 1.15322975 |
| 90 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.15054729 |
| 91 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.14440480 |
| 92 | STAT3_23295773_ChIP-Seq_U87_Human | 1.13868205 |
| 93 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.13530616 |
| 94 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.13391138 |
| 95 | FUS_26573619_Chip-Seq_HEK293_Human | 1.13273492 |
| 96 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.12315630 |
| 97 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.11982914 |
| 98 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.10889671 |
| 99 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.10487986 |
| 100 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.10208276 |
| 101 | CJUN_26792858_Chip-Seq_BT549_Human | 1.09583705 |
| 102 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.09007007 |
| 103 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.08719288 |
| 104 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.08401958 |
| 105 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.08399537 |
| 106 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.08118948 |
| 107 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.07930625 |
| 108 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.06616225 |
| 109 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.06392145 |
| 110 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.05643527 |
| 111 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.05331136 |
| 112 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.05124038 |
| 113 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.05045613 |
| 114 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.04549196 |
| 115 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.04412194 |
| 116 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.04307188 |
| 117 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.04233229 |
| 118 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.04143190 |
| 119 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.04112164 |
| 120 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.04061810 |
| 121 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.03848022 |
| 122 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.03747760 |
| 123 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.03477191 |
| 124 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.03413209 |
| 125 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.03285831 |
| 126 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.03127959 |
| 127 | RXR_22108803_ChIP-Seq_LS180_Human | 1.02627467 |
| 128 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.02616516 |
| 129 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.01729453 |
| 130 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.01413303 |
| 131 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.01265524 |
| 132 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.01084489 |
| 133 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.01030974 |
| 134 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.00789868 |
| 135 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00455440 |
| 136 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.00261411 |
| 137 | TCF4_23295773_ChIP-Seq_U87_Human | 0.99889077 |
| 138 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.99627261 |
| 139 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.99511430 |
| 140 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.98305852 |
| 141 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.97056581 |
| 142 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.96396260 |
| 143 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.96361327 |
| 144 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.95972206 |
| 145 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.95906625 |
| 146 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.95438064 |
| 147 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.94925082 |
| 148 | AR_19668381_ChIP-Seq_PC3_Human | 0.94416083 |
| 149 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.93721961 |
| 150 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.93054521 |
| 151 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.93036941 |
| 152 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.92621950 |
| 153 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.92508259 |
| 154 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.92392732 |
| 155 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.92012144 |
| 156 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.91130773 |
| 157 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.90826706 |
| 158 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.89733690 |
| 159 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.89681319 |
| 160 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.89432469 |
| 161 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.89394522 |
| 162 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.88905302 |
| 163 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.87851550 |
| 164 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.84756971 |
| 165 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.84477731 |
| 166 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.82244631 |
| 167 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.80774072 |
| 168 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.80648607 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.31896956 |
| 2 | MP0003880_abnormal_central_pattern | 4.20482147 |
| 3 | MP0004270_analgesia | 3.09878275 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 2.95168803 |
| 5 | MP0008438_abnormal_cutaneous_collagen | 2.77407894 |
| 6 | MP0009745_abnormal_behavioral_response | 2.68772881 |
| 7 | MP0002064_seizures | 2.50368487 |
| 8 | MP0002837_dystrophic_cardiac_calcinosis | 2.46564095 |
| 9 | MP0004510_myositis | 2.43248948 |
| 10 | MP0001486_abnormal_startle_reflex | 2.31813516 |
| 11 | MP0002272_abnormal_nervous_system | 2.31229280 |
| 12 | * MP0002063_abnormal_learning/memory/cond | 2.30719838 |
| 13 | MP0009046_muscle_twitch | 2.22596616 |
| 14 | MP0005275_abnormal_skin_tensile | 2.18999471 |
| 15 | MP0002822_catalepsy | 2.14633428 |
| 16 | MP0003329_amyloid_beta_deposits | 2.12315943 |
| 17 | MP0001440_abnormal_grooming_behavior | 2.12278859 |
| 18 | MP0004084_abnormal_cardiac_muscle | 2.12257711 |
| 19 | MP0009780_abnormal_chondrocyte_physiolo | 2.11323524 |
| 20 | MP0002572_abnormal_emotion/affect_behav | 2.11057284 |
| 21 | MP0004145_abnormal_muscle_electrophysio | 2.04608372 |
| 22 | MP0001501_abnormal_sleep_pattern | 2.02202125 |
| 23 | MP0002332_abnormal_exercise_endurance | 2.00805145 |
| 24 | MP0001968_abnormal_touch/_nociception | 1.96490158 |
| 25 | MP0003303_peritoneal_inflammation | 1.96102007 |
| 26 | MP0003279_aneurysm | 1.91578673 |
| 27 | MP0003705_abnormal_hypodermis_morpholog | 1.89449202 |
| 28 | MP0010368_abnormal_lymphatic_system | 1.86412477 |
| 29 | MP0005670_abnormal_white_adipose | 1.83522908 |
| 30 | MP0001958_emphysema | 1.82403409 |
| 31 | MP0003724_increased_susceptibility_to | 1.81422236 |
| 32 | MP0002139_abnormal_hepatobiliary_system | 1.80158660 |
| 33 | MP0002734_abnormal_mechanical_nocicepti | 1.76813134 |
| 34 | MP0004087_abnormal_muscle_fiber | 1.73817401 |
| 35 | MP0003690_abnormal_glial_cell | 1.73452684 |
| 36 | MP0003828_pulmonary_edema | 1.73376599 |
| 37 | MP0000920_abnormal_myelination | 1.73021976 |
| 38 | MP0004043_abnormal_pH_regulation | 1.69854056 |
| 39 | MP0003045_fibrosis | 1.68796471 |
| 40 | MP0003075_altered_response_to | 1.68701201 |
| 41 | MP0003300_gastrointestinal_ulcer | 1.64562444 |
| 42 | MP0004885_abnormal_endolymph | 1.63709723 |
| 43 | MP0003191_abnormal_cellular_cholesterol | 1.58506818 |
| 44 | MP0005503_abnormal_tendon_morphology | 1.55511042 |
| 45 | MP0005085_abnormal_gallbladder_physiolo | 1.55000612 |
| 46 | MP0000759_abnormal_skeletal_muscle | 1.53208450 |
| 47 | MP0002736_abnormal_nociception_after | 1.51098707 |
| 48 | MP0003091_abnormal_cell_migration | 1.48747374 |
| 49 | MP0009840_abnormal_foam_cell | 1.48368406 |
| 50 | MP0002067_abnormal_sensory_capabilities | 1.48326665 |
| 51 | MP0003136_yellow_coat_color | 1.47557437 |
| 52 | MP0005451_abnormal_body_composition | 1.47316450 |
| 53 | MP0003950_abnormal_plasma_membrane | 1.45746939 |
| 54 | MP0005166_decreased_susceptibility_to | 1.45059627 |
| 55 | MP0000751_myopathy | 1.42569476 |
| 56 | MP0002106_abnormal_muscle_physiology | 1.41956714 |
| 57 | MP0008004_abnormal_stomach_pH | 1.40306987 |
| 58 | MP0005165_increased_susceptibility_to | 1.39775999 |
| 59 | MP0008875_abnormal_xenobiotic_pharmacok | 1.37487660 |
| 60 | MP0002971_abnormal_brown_adipose | 1.34542442 |
| 61 | MP0005423_abnormal_somatic_nervous | 1.33220236 |
| 62 | MP0005360_urolithiasis | 1.32619212 |
| 63 | MP0004130_abnormal_muscle_cell | 1.31954483 |
| 64 | MP0002972_abnormal_cardiac_muscle | 1.31683052 |
| 65 | MP0002998_abnormal_bone_remodeling | 1.31188557 |
| 66 | MP0000778_abnormal_nervous_system | 1.30083235 |
| 67 | MP0002733_abnormal_thermal_nociception | 1.29367730 |
| 68 | MP0003633_abnormal_nervous_system | 1.29086125 |
| 69 | MP0001970_abnormal_pain_threshold | 1.28683209 |
| 70 | MP0003195_calcinosis | 1.28388868 |
| 71 | MP0005375_adipose_tissue_phenotype | 1.28288173 |
| 72 | MP0005386_behavior/neurological_phenoty | 1.27035671 |
| 73 | MP0004924_abnormal_behavior | 1.27035671 |
| 74 | MP0005369_muscle_phenotype | 1.26950256 |
| 75 | MP0008569_lethality_at_weaning | 1.23654177 |
| 76 | MP0004142_abnormal_muscle_tone | 1.22673571 |
| 77 | MP0001851_eye_inflammation | 1.22637775 |
| 78 | MP0001529_abnormal_vocalization | 1.22029546 |
| 79 | MP0005551_abnormal_eye_electrophysiolog | 1.20541134 |
| 80 | MP0004215_abnormal_myocardial_fiber | 1.20393478 |
| 81 | MP0004036_abnormal_muscle_relaxation | 1.20239334 |
| 82 | MP0005023_abnormal_wound_healing | 1.18086727 |
| 83 | MP0000343_altered_response_to | 1.18042795 |
| 84 | MP0005535_abnormal_body_temperature | 1.16795779 |
| 85 | MP0004484_altered_response_of | 1.16121093 |
| 86 | MP0002269_muscular_atrophy | 1.15951895 |
| 87 | MP0001905_abnormal_dopamine_level | 1.15556334 |
| 88 | MP0002735_abnormal_chemical_nociception | 1.15176010 |
| 89 | * MP0002066_abnormal_motor_capabilities/c | 1.14930671 |
| 90 | MP0003436_decreased_susceptibility_to | 1.13721668 |
| 91 | MP0005171_absent_coat_pigmentation | 1.12730549 |
| 92 | MP0005164_abnormal_response_to | 1.11595835 |
| 93 | MP0005058_abnormal_lysosome_morphology | 1.11032212 |
| 94 | MP0003631_nervous_system_phenotype | 1.10761776 |
| 95 | MP0000747_muscle_weakness | 1.09690119 |
| 96 | MP0002909_abnormal_adrenal_gland | 1.09672350 |
| 97 | MP0001879_abnormal_lymphatic_vessel | 1.09146642 |
| 98 | MP0000749_muscle_degeneration | 1.08811366 |
| 99 | MP0000750_abnormal_muscle_regeneration | 1.08762324 |
| 100 | MP0008874_decreased_physiological_sensi | 1.07994125 |
| 101 | MP0005332_abnormal_amino_acid | 1.07527472 |
| 102 | MP0001533_abnormal_skeleton_physiology | 1.07265177 |
| 103 | MP0003566_abnormal_cell_adhesion | 1.07159483 |
| 104 | MP0000955_abnormal_spinal_cord | 1.07044898 |
| 105 | MP0000013_abnormal_adipose_tissue | 1.06719151 |
| 106 | MP0001661_extended_life_span | 1.06606056 |
| 107 | MP0004185_abnormal_adipocyte_glucose | 1.06578916 |
| 108 | MP0002557_abnormal_social/conspecific_i | 1.06323172 |
| 109 | MP0005623_abnormal_meninges_morphology | 1.04866714 |
| 110 | MP0005385_cardiovascular_system_phenoty | 1.04604426 |
| 111 | MP0001544_abnormal_cardiovascular_syste | 1.04604426 |
| 112 | MP0005409_darkened_coat_color | 1.03534366 |
| 113 | MP0002229_neurodegeneration | 1.03386771 |
| 114 | MP0002933_joint_inflammation | 1.01277737 |
| 115 | MP0003656_abnormal_erythrocyte_physiolo | 1.00201504 |
| 116 | MP0005646_abnormal_pituitary_gland | 0.99817177 |
| 117 | MP0002254_reproductive_system_inflammat | 0.99747972 |
| 118 | MP0005365_abnormal_bile_salt | 0.99403216 |
| 119 | MP0002882_abnormal_neuron_morphology | 0.99336924 |
| 120 | MP0000733_abnormal_muscle_development | 0.98557062 |
| 121 | MP0004085_abnormal_heartbeat | 0.98247639 |
| 122 | MP0000604_amyloidosis | 0.97217463 |
| 123 | MP0001502_abnormal_circadian_rhythm | 0.96976668 |
| 124 | MP0004947_skin_inflammation | 0.96902921 |
| 125 | MP0003646_muscle_fatigue | 0.96857325 |
| 126 | MP0004742_abnormal_vestibular_system | 0.96494734 |
| 127 | MP0003868_abnormal_feces_composition | 0.96372201 |
| 128 | MP0003634_abnormal_glial_cell | 0.95776265 |
| 129 | MP0004272_abnormal_basement_membrane | 0.95544798 |
| 130 | MP0005620_abnormal_muscle_contractility | 0.95273662 |
| 131 | MP0003632_abnormal_nervous_system | 0.94994497 |
| 132 | MP0001485_abnormal_pinna_reflex | 0.94227795 |
| 133 | MP0010630_abnormal_cardiac_muscle | 0.93816131 |
| 134 | MP0000249_abnormal_blood_vessel | 0.93351441 |
| 135 | MP0002184_abnormal_innervation | 0.93223223 |
| 136 | MP0000767_abnormal_smooth_muscle | 0.92757567 |
| 137 | MP0002009_preneoplasia | 0.92222890 |
| 138 | MP0003806_abnormal_nucleotide_metabolis | 0.91296727 |
| 139 | MP0006082_CNS_inflammation | 0.90600214 |
| 140 | MP0001177_atelectasis | 0.90381182 |
| 141 | MP0003879_abnormal_hair_cell | 0.89740193 |
| 142 | MP0000003_abnormal_adipose_tissue | 0.89323586 |
| 143 | MP0001984_abnormal_olfaction | 0.87731724 |
| 144 | MP0004233_abnormal_muscle_weight | 0.87582543 |
| 145 | MP0006276_abnormal_autonomic_nervous | 0.86710051 |
| 146 | MP0003137_abnormal_impulse_conducting | 0.86513639 |
| 147 | MP0010329_abnormal_lipoprotein_level | 0.86263805 |
| 148 | MP0005595_abnormal_vascular_smooth | 0.86100071 |
| 149 | MP0004858_abnormal_nervous_system | 0.85453930 |
| 150 | MP0005167_abnormal_blood-brain_barrier | 0.84534142 |
| 151 | MP0008775_abnormal_heart_ventricle | 0.83753053 |
| 152 | MP0005330_cardiomyopathy | 0.83539782 |
| 153 | MP0003453_abnormal_keratinocyte_physiol | 0.83373337 |
| 154 | MP0001963_abnormal_hearing_physiology | 0.82664707 |
| 155 | MP0002118_abnormal_lipid_homeostasis | 0.81897487 |
| 156 | MP0005666_abnormal_adipose_tissue | 0.81055479 |
| 157 | MP0002090_abnormal_vision | 0.79751746 |
| 158 | MP0008872_abnormal_physiological_respon | 0.79378906 |
| 159 | MP0002295_abnormal_pulmonary_circulatio | 0.77705350 |
| 160 | MP0002896_abnormal_bone_mineralization | 0.77301167 |
| 161 | MP0002108_abnormal_muscle_morphology | 0.75712149 |
| 162 | MP0006138_congestive_heart_failure | 0.75584147 |
| 163 | MP0002876_abnormal_thyroid_physiology | 0.74492907 |
| 164 | MP0002133_abnormal_respiratory_system | 0.72636544 |
| 165 | MP0005388_respiratory_system_phenotype | 0.72636544 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.49723446 |
| 2 | Type 1 muscle fiber predominance (HP:0003803) | 4.60398126 |
| 3 | Muscle fiber inclusion bodies (HP:0100299) | 4.47859971 |
| 4 | Nemaline bodies (HP:0003798) | 4.42340321 |
| 5 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.33918768 |
| 6 | Focal seizures (HP:0007359) | 3.91446474 |
| 7 | Myokymia (HP:0002411) | 3.80944773 |
| 8 | Neurofibrillary tangles (HP:0002185) | 3.76713766 |
| 9 | Hyperventilation (HP:0002883) | 3.72702267 |
| 10 | Complement deficiency (HP:0004431) | 3.64869927 |
| 11 | Cerebral inclusion bodies (HP:0100314) | 3.63030420 |
| 12 | Aortic aneurysm (HP:0004942) | 3.50872688 |
| 13 | Asymmetric septal hypertrophy (HP:0001670) | 3.39443857 |
| 14 | Atonic seizures (HP:0010819) | 3.39098761 |
| 15 | Visual hallucinations (HP:0002367) | 3.34779604 |
| 16 | Bundle branch block (HP:0011710) | 3.32458457 |
| 17 | Increased variability in muscle fiber diameter (HP:0003557) | 3.23953346 |
| 18 | Systemic lupus erythematosus (HP:0002725) | 3.17690054 |
| 19 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.17122636 |
| 20 | Epileptic encephalopathy (HP:0200134) | 3.14266091 |
| 21 | Abnormality of complement system (HP:0005339) | 3.07811612 |
| 22 | Increased connective tissue (HP:0009025) | 3.02539742 |
| 23 | Scanning speech (HP:0002168) | 2.89536530 |
| 24 | Distal lower limb muscle weakness (HP:0009053) | 2.85527479 |
| 25 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.84189434 |
| 26 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.84189434 |
| 27 | Absence seizures (HP:0002121) | 2.83485561 |
| 28 | Dysdiadochokinesis (HP:0002075) | 2.81567396 |
| 29 | Dialeptic seizures (HP:0011146) | 2.80535545 |
| 30 | Dysmetria (HP:0001310) | 2.80200842 |
| 31 | Generalized tonic-clonic seizures (HP:0002069) | 2.75582278 |
| 32 | Cerebral aneurysm (HP:0004944) | 2.75234642 |
| 33 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.71629614 |
| 34 | Glomerulonephritis (HP:0000099) | 2.68622679 |
| 35 | Action tremor (HP:0002345) | 2.68335423 |
| 36 | Broad-based gait (HP:0002136) | 2.66209209 |
| 37 | Neck muscle weakness (HP:0000467) | 2.62453755 |
| 38 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.61710452 |
| 39 | Subaortic stenosis (HP:0001682) | 2.61710452 |
| 40 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.60789226 |
| 41 | Abnormality of the corticospinal tract (HP:0002492) | 2.56264459 |
| 42 | Protrusio acetabuli (HP:0003179) | 2.55459352 |
| 43 | Round ear (HP:0100830) | 2.53900120 |
| 44 | Febrile seizures (HP:0002373) | 2.49491327 |
| 45 | Obstructive sleep apnea (HP:0002870) | 2.47182209 |
| 46 | Exercise-induced muscle cramps (HP:0003710) | 2.46117495 |
| 47 | Intention tremor (HP:0002080) | 2.41916973 |
| 48 | Exercise-induced myalgia (HP:0003738) | 2.41027889 |
| 49 | Abnormal atrioventricular conduction (HP:0005150) | 2.40382091 |
| 50 | Increased circulating renin level (HP:0000848) | 2.38736115 |
| 51 | Gaze-evoked nystagmus (HP:0000640) | 2.37715677 |
| 52 | Heart block (HP:0012722) | 2.36703469 |
| 53 | Progressive cerebellar ataxia (HP:0002073) | 2.36204046 |
| 54 | Aortic dissection (HP:0002647) | 2.34609970 |
| 55 | Calf muscle hypertrophy (HP:0008981) | 2.33560401 |
| 56 | Hemiparesis (HP:0001269) | 2.32213895 |
| 57 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.29387137 |
| 58 | Aplasia of the phalanges of the hand (HP:0009802) | 2.29387137 |
| 59 | Aplasia involving bones of the extremities (HP:0009825) | 2.29387137 |
| 60 | Status epilepticus (HP:0002133) | 2.27308690 |
| 61 | Anxiety (HP:0000739) | 2.27205339 |
| 62 | Hyperlipoproteinemia (HP:0010980) | 2.26973202 |
| 63 | Confusion (HP:0001289) | 2.23935651 |
| 64 | Ketoacidosis (HP:0001993) | 2.23293470 |
| 65 | Atrioventricular block (HP:0001678) | 2.22439771 |
| 66 | Peripheral hypomyelination (HP:0007182) | 2.18624948 |
| 67 | Poor eye contact (HP:0000817) | 2.18404484 |
| 68 | Termporal pattern (HP:0011008) | 2.18311345 |
| 69 | Insidious onset (HP:0003587) | 2.18311345 |
| 70 | Distal lower limb amyotrophy (HP:0008944) | 2.17540779 |
| 71 | Xanthomatosis (HP:0000991) | 2.16604677 |
| 72 | Distal arthrogryposis (HP:0005684) | 2.16428025 |
| 73 | Amblyopia (HP:0000646) | 2.16140655 |
| 74 | Supranuclear gaze palsy (HP:0000605) | 2.15340169 |
| 75 | Intrahepatic cholestasis (HP:0001406) | 2.14874731 |
| 76 | Ulnar deviation of the wrist (HP:0003049) | 2.14281928 |
| 77 | Rhabdomyolysis (HP:0003201) | 2.13914010 |
| 78 | Abnormal social behavior (HP:0012433) | 2.13040256 |
| 79 | Impaired social interactions (HP:0000735) | 2.13040256 |
| 80 | Frequent falls (HP:0002359) | 2.12898786 |
| 81 | Sudden death (HP:0001699) | 2.12826015 |
| 82 | Ketosis (HP:0001946) | 2.11925689 |
| 83 | Foot dorsiflexor weakness (HP:0009027) | 2.11037978 |
| 84 | Hyperglycinemia (HP:0002154) | 2.10106044 |
| 85 | Abnormality of glycine metabolism (HP:0010895) | 2.09818796 |
| 86 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.09818796 |
| 87 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.07575772 |
| 88 | Hypoplasia of the iris (HP:0007676) | 2.06271997 |
| 89 | Sensory axonal neuropathy (HP:0003390) | 2.06197322 |
| 90 | Deep venous thrombosis (HP:0002625) | 2.06167585 |
| 91 | Vascular tortuosity (HP:0004948) | 2.05718535 |
| 92 | Aneurysm (HP:0002617) | 2.05055476 |
| 93 | Ventricular fibrillation (HP:0001663) | 2.04791066 |
| 94 | Cerebral hemorrhage (HP:0001342) | 2.04162956 |
| 95 | Abnormality of the Achilles tendon (HP:0005109) | 2.03390579 |
| 96 | Bulbar palsy (HP:0001283) | 2.01987420 |
| 97 | Abnormality of the foot musculature (HP:0001436) | 2.01907440 |
| 98 | Ventricular arrhythmia (HP:0004308) | 2.00638372 |
| 99 | Myoglobinuria (HP:0002913) | 2.00419466 |
| 100 | Generalized myoclonic seizures (HP:0002123) | 2.00248948 |
| 101 | Myopathic facies (HP:0002058) | 2.00225621 |
| 102 | Muscle fiber splitting (HP:0003555) | 1.99608037 |
| 103 | Hyporeflexia of lower limbs (HP:0002600) | 1.99214240 |
| 104 | Metabolic alkalosis (HP:0200114) | 1.97927340 |
| 105 | Amyloidosis (HP:0011034) | 1.97050318 |
| 106 | Polycythemia (HP:0001901) | 1.96641723 |
| 107 | Abnormality of the calf musculature (HP:0001430) | 1.96065391 |
| 108 | Achilles tendon contracture (HP:0001771) | 1.95687540 |
| 109 | Clumsiness (HP:0002312) | 1.95517372 |
| 110 | Testicular atrophy (HP:0000029) | 1.95233650 |
| 111 | Myocardial infarction (HP:0001658) | 1.93934427 |
| 112 | Nephritis (HP:0000123) | 1.92911821 |
| 113 | Spinal rigidity (HP:0003306) | 1.92302934 |
| 114 | Epileptiform EEG discharges (HP:0011182) | 1.91829993 |
| 115 | Dysmetric saccades (HP:0000641) | 1.91357869 |
| 116 | Interstitial pulmonary disease (HP:0006530) | 1.91165222 |
| 117 | Arterial tortuosity (HP:0005116) | 1.91094239 |
| 118 | EMG: neuropathic changes (HP:0003445) | 1.90500891 |
| 119 | Acute encephalopathy (HP:0006846) | 1.90479288 |
| 120 | Delusions (HP:0000746) | 1.89925596 |
| 121 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.89431433 |
| 122 | Truncal ataxia (HP:0002078) | 1.88597416 |
| 123 | Hyperkalemia (HP:0002153) | 1.88002821 |
| 124 | Abnormality of binocular vision (HP:0011514) | 1.87474990 |
| 125 | Diplopia (HP:0000651) | 1.87474990 |
| 126 | Hypokalemic alkalosis (HP:0001949) | 1.87011642 |
| 127 | Absent speech (HP:0001344) | 1.85551814 |
| 128 | Axonal loss (HP:0003447) | 1.85002899 |
| 129 | Lower limb amyotrophy (HP:0007210) | 1.84659204 |
| 130 | Ventricular tachycardia (HP:0004756) | 1.83542807 |
| 131 | Lipoatrophy (HP:0100578) | 1.83136195 |
| 132 | Atrial fibrillation (HP:0005110) | 1.83050927 |
| 133 | Osteolytic defects of the hand bones (HP:0009699) | 1.81855500 |
| 134 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.81855500 |
| 135 | Hyperglycinuria (HP:0003108) | 1.81533511 |
| 136 | Hypoplastic ischia (HP:0003175) | 1.80858638 |
| 137 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.79990243 |
| 138 | Acute necrotizing encephalopathy (HP:0006965) | 1.79684845 |
| 139 | EEG with generalized epileptiform discharges (HP:0011198) | 1.78648840 |
| 140 | Pheochromocytoma (HP:0002666) | 1.78237934 |
| 141 | Postural instability (HP:0002172) | 1.77823106 |
| 142 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.77595096 |
| 143 | Gout (HP:0001997) | 1.76597819 |
| 144 | Cerebral edema (HP:0002181) | 1.76443677 |
| 145 | Abnormality of the ischium (HP:0003174) | 1.74513750 |
| 146 | Progressive macrocephaly (HP:0004481) | 1.74287307 |
| 147 | Muscle stiffness (HP:0003552) | 1.74129907 |
| 148 | EMG: myopathic abnormalities (HP:0003458) | 1.73398222 |
| 149 | Onion bulb formation (HP:0003383) | 1.73390251 |
| 150 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.72940659 |
| 151 | Primary atrial arrhythmia (HP:0001692) | 1.70999724 |
| 152 | Dysostosis multiplex (HP:0000943) | 1.70821695 |
| 153 | Prolonged partial thromboplastin time (HP:0003645) | 1.70806442 |
| 154 | Blue irides (HP:0000635) | 1.70597517 |
| 155 | Papilledema (HP:0001085) | 1.69891381 |
| 156 | Megalencephaly (HP:0001355) | 1.68124810 |
| 157 | Depression (HP:0000716) | 1.68077574 |
| 158 | Overgrowth (HP:0001548) | 1.67970128 |
| 159 | Syncope (HP:0001279) | 1.67612775 |
| 160 | Scapular winging (HP:0003691) | 1.67146824 |
| 161 | Hypoalphalipoproteinemia (HP:0003233) | 1.66950738 |
| 162 | Spastic gait (HP:0002064) | 1.66675482 |
| 163 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.66543651 |
| 164 | Abnormal eating behavior (HP:0100738) | 1.66382082 |
| 165 | Impaired vibratory sensation (HP:0002495) | 1.65894107 |
| 166 | Difficulty running (HP:0009046) | 1.65891197 |
| 167 | Increased CSF protein (HP:0002922) | 1.65831004 |
| 168 | Bronchomalacia (HP:0002780) | 1.65419960 |
| 169 | Hypsarrhythmia (HP:0002521) | 1.64696144 |
| 170 | Methylmalonic acidemia (HP:0002912) | 1.64568978 |
| 171 | Retinal dysplasia (HP:0007973) | 1.64283318 |
| 172 | Spondylolisthesis (HP:0003302) | 1.64278281 |
| 173 | Right ventricular cardiomyopathy (HP:0011663) | 1.63627268 |
| 174 | Abnormality of glycolipid metabolism (HP:0010969) | 1.63500458 |
| 175 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.63500458 |
| 176 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.63500458 |
| 177 | Joint hemorrhage (HP:0005261) | 1.63476941 |
| 178 | Wormian bones (HP:0002645) | 1.63180496 |
| 179 | Dilatation of the ascending aorta (HP:0005111) | 1.62867885 |
| 180 | Mitral stenosis (HP:0001718) | 1.62696392 |
| 181 | Slender build (HP:0001533) | 1.61456192 |
| 182 | Spontaneous hematomas (HP:0007420) | 1.61031929 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.91906160 |
| 2 | RIPK1 | 3.23224658 |
| 3 | NTRK3 | 3.19266820 |
| 4 | TTN | 3.18821926 |
| 5 | STK39 | 2.59667430 |
| 6 | PNCK | 2.54475155 |
| 7 | OXSR1 | 2.42801613 |
| 8 | RIPK4 | 2.39121040 |
| 9 | MAP3K4 | 2.24578238 |
| 10 | MAP3K9 | 2.22770887 |
| 11 | MYLK | 2.16560558 |
| 12 | NTRK1 | 2.04144486 |
| 13 | MAP2K4 | 2.01157011 |
| 14 | CASK | 2.00940404 |
| 15 | DAPK2 | 1.90807090 |
| 16 | TGFBR2 | 1.77618267 |
| 17 | TRPM7 | 1.72162618 |
| 18 | MAP2K7 | 1.66328796 |
| 19 | MUSK | 1.60252068 |
| 20 | MINK1 | 1.57964748 |
| 21 | GRK5 | 1.57351380 |
| 22 | TNIK | 1.51555816 |
| 23 | MAP3K3 | 1.51128915 |
| 24 | BMPR2 | 1.47885130 |
| 25 | PAK6 | 1.45847717 |
| 26 | WNK4 | 1.44880938 |
| 27 | PIK3CG | 1.43889006 |
| 28 | PINK1 | 1.42948568 |
| 29 | JAK1 | 1.39117745 |
| 30 | FES | 1.38272889 |
| 31 | NME1 | 1.37160289 |
| 32 | PDGFRA | 1.36791543 |
| 33 | KSR2 | 1.35177303 |
| 34 | MAP2K3 | 1.34984995 |
| 35 | ERN1 | 1.33541123 |
| 36 | PTK2B | 1.32231036 |
| 37 | SGK3 | 1.29497003 |
| 38 | PLK2 | 1.29492427 |
| 39 | CAMK2B | 1.28992264 |
| 40 | MAPK7 | 1.28719188 |
| 41 | CAMK2A | 1.27243181 |
| 42 | TYRO3 | 1.26835909 |
| 43 | SGK2 | 1.25899046 |
| 44 | PRKD3 | 1.23900967 |
| 45 | FGR | 1.23587423 |
| 46 | FGFR3 | 1.23258895 |
| 47 | TRIB3 | 1.21799173 |
| 48 | MAP3K2 | 1.19009648 |
| 49 | MOS | 1.15876031 |
| 50 | PHKG1 | 1.11710817 |
| 51 | PHKG2 | 1.11710817 |
| 52 | FER | 1.11529764 |
| 53 | CDK5 | 1.11381921 |
| 54 | EPHA3 | 1.11275024 |
| 55 | MAP3K12 | 1.09969980 |
| 56 | CAMK2D | 1.08031675 |
| 57 | AKT3 | 1.07363195 |
| 58 | PKN1 | 1.07244815 |
| 59 | BLK | 1.06425021 |
| 60 | CDC42BPA | 1.06299985 |
| 61 | TYK2 | 1.03068288 |
| 62 | SGK223 | 1.02954624 |
| 63 | SGK494 | 1.02954624 |
| 64 | INSRR | 1.00853935 |
| 65 | NEK9 | 1.00726660 |
| 66 | EEF2K | 1.00239124 |
| 67 | MAP3K14 | 0.99736760 |
| 68 | ZAP70 | 0.99714425 |
| 69 | FGFR2 | 0.96540808 |
| 70 | PDK2 | 0.93065498 |
| 71 | PRKAA2 | 0.92763494 |
| 72 | PRKCG | 0.92079839 |
| 73 | CAMK2G | 0.90082439 |
| 74 | PDGFRB | 0.89761986 |
| 75 | PRKCE | 0.88276712 |
| 76 | PDPK1 | 0.88129194 |
| 77 | NTRK2 | 0.87317023 |
| 78 | PRPF4B | 0.86510204 |
| 79 | MAPKAPK5 | 0.86324510 |
| 80 | DMPK | 0.85537293 |
| 81 | TBK1 | 0.85356964 |
| 82 | FGFR4 | 0.85104971 |
| 83 | NLK | 0.84542827 |
| 84 | CDK19 | 0.84534436 |
| 85 | EPHB1 | 0.82946864 |
| 86 | NEK6 | 0.82064727 |
| 87 | JAK2 | 0.81673471 |
| 88 | TAOK2 | 0.80558349 |
| 89 | MAPK4 | 0.80307020 |
| 90 | PAK3 | 0.79962080 |
| 91 | PDK3 | 0.79880826 |
| 92 | PDK4 | 0.79880826 |
| 93 | MET | 0.77742213 |
| 94 | HIPK2 | 0.77233487 |
| 95 | STK38 | 0.77203815 |
| 96 | ROCK2 | 0.77070342 |
| 97 | SIK1 | 0.76792682 |
| 98 | BCKDK | 0.76239324 |
| 99 | WNK1 | 0.75932576 |
| 100 | CAMKK2 | 0.75897289 |
| 101 | MAP3K13 | 0.74907086 |
| 102 | BCR | 0.73797496 |
| 103 | IRAK3 | 0.73135350 |
| 104 | STK11 | 0.72862055 |
| 105 | SGK1 | 0.70916221 |
| 106 | IKBKE | 0.68905441 |
| 107 | OBSCN | 0.68888788 |
| 108 | GRK7 | 0.67746714 |
| 109 | PAK2 | 0.66726649 |
| 110 | CAMK4 | 0.66487770 |
| 111 | MAPK15 | 0.65613750 |
| 112 | KSR1 | 0.64556660 |
| 113 | CAMK1 | 0.64148164 |
| 114 | ARAF | 0.64093749 |
| 115 | CAMKK1 | 0.63816002 |
| 116 | PDK1 | 0.63276060 |
| 117 | CAMK1G | 0.62484751 |
| 118 | UHMK1 | 0.59949402 |
| 119 | TIE1 | 0.59023287 |
| 120 | MARK1 | 0.58507471 |
| 121 | MAP3K6 | 0.57571930 |
| 122 | DYRK1A | 0.57051701 |
| 123 | MAP3K7 | 0.56122616 |
| 124 | DAPK1 | 0.56112498 |
| 125 | CSK | 0.56041983 |
| 126 | DDR2 | 0.55707652 |
| 127 | MARK2 | 0.55112118 |
| 128 | ABL2 | 0.54912744 |
| 129 | MAPK12 | 0.54729469 |
| 130 | MAPKAPK3 | 0.54300969 |
| 131 | RET | 0.53340320 |
| 132 | PRKACA | 0.53093430 |
| 133 | WNK3 | 0.52709810 |
| 134 | PRKD2 | 0.52093860 |
| 135 | MAP2K1 | 0.50430222 |
| 136 | GSK3A | 0.50102359 |
| 137 | MAPK11 | 0.49729334 |
| 138 | CDK14 | 0.48693102 |
| 139 | ICK | 0.48497663 |
| 140 | LATS2 | 0.48214013 |
| 141 | MAP3K1 | 0.47554851 |
| 142 | MAPK13 | 0.47482725 |
| 143 | PRKD1 | 0.47217478 |
| 144 | PIK3CA | 0.46917087 |
| 145 | PRKCH | 0.46437909 |
| 146 | MAPK10 | 0.45267739 |
| 147 | IRAK1 | 0.45140708 |
| 148 | RPS6KA2 | 0.44932472 |
| 149 | ROCK1 | 0.44382290 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.20120722 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 2.47456591 |
| 3 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.03646043 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 1.96712803 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.95234205 |
| 6 | Long-term potentiation_Homo sapiens_hsa04720 | 1.92973420 |
| 7 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.84240094 |
| 8 | Salivary secretion_Homo sapiens_hsa04970 | 1.83041006 |
| 9 | Circadian entrainment_Homo sapiens_hsa04713 | 1.82299642 |
| 10 | Circadian rhythm_Homo sapiens_hsa04710 | 1.66775567 |
| 11 | Morphine addiction_Homo sapiens_hsa05032 | 1.62395343 |
| 12 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.60359181 |
| 13 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.57022840 |
| 14 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.56559138 |
| 15 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.55323840 |
| 16 | Renin secretion_Homo sapiens_hsa04924 | 1.55264855 |
| 17 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.48516738 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.47324013 |
| 19 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.44780012 |
| 20 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.41240119 |
| 21 | Insulin secretion_Homo sapiens_hsa04911 | 1.38531381 |
| 22 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.37692448 |
| 23 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.37353269 |
| 24 | Long-term depression_Homo sapiens_hsa04730 | 1.36035834 |
| 25 | Taste transduction_Homo sapiens_hsa04742 | 1.35929101 |
| 26 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.35400911 |
| 27 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.35019951 |
| 28 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.34739481 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.33127750 |
| 30 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.32338861 |
| 31 | Olfactory transduction_Homo sapiens_hsa04740 | 1.31062624 |
| 32 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.30712213 |
| 33 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.29402612 |
| 34 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.28239929 |
| 35 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.28121545 |
| 36 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.27975836 |
| 37 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.27617773 |
| 38 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.26021969 |
| 39 | Malaria_Homo sapiens_hsa05144 | 1.22837170 |
| 40 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.22296158 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.20978787 |
| 42 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.20420425 |
| 43 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.17316813 |
| 44 | Alzheimers disease_Homo sapiens_hsa05010 | 1.16172201 |
| 45 | Amoebiasis_Homo sapiens_hsa05146 | 1.14593882 |
| 46 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.14477500 |
| 47 | Insulin resistance_Homo sapiens_hsa04931 | 1.14444537 |
| 48 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.14074030 |
| 49 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.12145109 |
| 50 | Pertussis_Homo sapiens_hsa05133 | 1.11908225 |
| 51 | Bile secretion_Homo sapiens_hsa04976 | 1.11873076 |
| 52 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.11064246 |
| 53 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.10145969 |
| 54 | Focal adhesion_Homo sapiens_hsa04510 | 1.03724331 |
| 55 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.03484893 |
| 56 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.02250955 |
| 57 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.01508279 |
| 58 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.99317118 |
| 59 | Cocaine addiction_Homo sapiens_hsa05030 | 0.97936597 |
| 60 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.97921710 |
| 61 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.97419218 |
| 62 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.96694589 |
| 63 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.92149299 |
| 64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.92082444 |
| 65 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.91608245 |
| 66 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.91310930 |
| 67 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.90106678 |
| 68 | Platelet activation_Homo sapiens_hsa04611 | 0.89290494 |
| 69 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.87647087 |
| 70 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.87438509 |
| 71 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.84681285 |
| 72 | Other glycan degradation_Homo sapiens_hsa00511 | 0.84051281 |
| 73 | Gap junction_Homo sapiens_hsa04540 | 0.83966258 |
| 74 | Parkinsons disease_Homo sapiens_hsa05012 | 0.82892567 |
| 75 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.82305605 |
| 76 | Phototransduction_Homo sapiens_hsa04744 | 0.81479952 |
| 77 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.80520024 |
| 78 | Leishmaniasis_Homo sapiens_hsa05140 | 0.79033374 |
| 79 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.78632714 |
| 80 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.78297894 |
| 81 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.78083806 |
| 82 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.78055367 |
| 83 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.77583481 |
| 84 | Glioma_Homo sapiens_hsa05214 | 0.76700345 |
| 85 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.76154943 |
| 86 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.76089535 |
| 87 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.75926829 |
| 88 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.75851705 |
| 89 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.75678494 |
| 90 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.74742688 |
| 91 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.74647483 |
| 92 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.74222641 |
| 93 | Histidine metabolism_Homo sapiens_hsa00340 | 0.74110875 |
| 94 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.73648651 |
| 95 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.72883274 |
| 96 | Mineral absorption_Homo sapiens_hsa04978 | 0.70992676 |
| 97 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.70642813 |
| 98 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.70327706 |
| 99 | Axon guidance_Homo sapiens_hsa04360 | 0.70034286 |
| 100 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.69640341 |
| 101 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.69084751 |
| 102 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.69027315 |
| 103 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.68751481 |
| 104 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.68409835 |
| 105 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.67973330 |
| 106 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.67947821 |
| 107 | ABC transporters_Homo sapiens_hsa02010 | 0.67887939 |
| 108 | Peroxisome_Homo sapiens_hsa04146 | 0.66687600 |
| 109 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.66317542 |
| 110 | Melanogenesis_Homo sapiens_hsa04916 | 0.66262165 |
| 111 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.65884559 |
| 112 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.65108117 |
| 113 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.64284295 |
| 114 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.64249411 |
| 115 | Tuberculosis_Homo sapiens_hsa05152 | 0.63775629 |
| 116 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.63515989 |
| 117 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.61570596 |
| 118 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.61259331 |
| 119 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.61146720 |
| 120 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.60161522 |
| 121 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.59771902 |
| 122 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.59143972 |
| 123 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.58792873 |
| 124 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.57634147 |
| 125 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.56994745 |
| 126 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.56666492 |
| 127 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.56107711 |
| 128 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.56046964 |
| 129 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.55978620 |
| 130 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.55328905 |
| 131 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.54785403 |
| 132 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.54717290 |
| 133 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.54182445 |
| 134 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.53625537 |
| 135 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.53540103 |
| 136 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.53465601 |
| 137 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.53233429 |
| 138 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.52424286 |
| 139 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.51428375 |
| 140 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.51349676 |
| 141 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.51301280 |
| 142 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.50143446 |
| 143 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.49923256 |
| 144 | Lysosome_Homo sapiens_hsa04142 | 0.49228732 |
| 145 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.48214272 |
| 146 | Prion diseases_Homo sapiens_hsa05020 | 0.47946750 |
| 147 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.47223172 |
| 148 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.46562202 |
| 149 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.46368740 |
| 150 | Huntingtons disease_Homo sapiens_hsa05016 | 0.46207463 |
| 151 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.46083265 |

